galantamine has been researched along with Amyloid Deposits in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, S; Haertel, C; Maelicke, A; Montag, D | 1 |
| Bhattacharya, S; Maelicke, A; Montag, D | 1 |
| Agarwal, S; Arora, N; Devi, CS; Mittal, N; Mohanasrinivasan, V; Priyadoss, CG; Saxena, S; Singh, B | 1 |
| Abe, K; Feng, T; Fukui, Y; Hishikawa, N; Morihara, R; Nakano, Y; Ohta, Y; Shang, J; Sun, Z; Yamashita, T; Zhai, Y | 1 |
| Bolognesi, ML; Cavalli, A; Melchiorre, C | 1 |
| Agostinho, P; Garção, P; Melo, JB; Oliveira, CR; Sousa, C | 1 |
| Caraci, F; Drago, F; Fedotova, J; Leggio, GM; Salomone, S | 1 |
| Ritter, JM | 1 |
| Blennow, K; de Leon, MJ; Zetterberg, H | 1 |
| Sivaprakasam, K | 1 |
4 review(s) available for galantamine and Amyloid Deposits
| Article | Year |
|---|---|
Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease.
Topics: Alkanes; Alzheimer Disease; Amides; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Anisoles; Antioxidants; Aspartic Acid Endopeptidases; Attention; Choline; Drug Design; Ethylamines; Galantamine; Humans; Memory; Neurons; Phosphorylation; Plaque, Amyloid; Platelet Aggregation Inhibitors; tau Proteins | 2009 |
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.
Topics: Alzheimer Disease; Clinical Trials as Topic; Donepezil; Drug Discovery; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Phenylcarbamates; Piperidines; Plaque, Amyloid; Rivastigmine; tau Proteins | 2012 |
Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Male; Molecular Biology; Phenylcarbamates; Piperidines; Plaque, Amyloid; Positron-Emission Tomography; Randomized Controlled Trials as Topic; Rivastigmine; tau Proteins | 2006 |
Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation.
Topics: Alkaloids; Alzheimer Disease; Amyloid; Cholinergic Fibers; Cholinesterase Inhibitors; Galantamine; Inflammation; Neurofibrillary Tangles; Plaque, Amyloid; Receptors, Nicotinic; Sesquiterpenes | 2006 |
6 other study(ies) available for galantamine and Amyloid Deposits
| Article | Year |
|---|---|
Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Disease Models, Animal; Female; Galantamine; Male; Maze Learning; Mice; Neurons; Plaque, Amyloid; Sex Factors | 2014 |
Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Cholinesterase Inhibitors; Conditioning, Psychological; Disease Models, Animal; Fear; Galantamine; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Muscle Strength; Mutation; Plaque, Amyloid; Presenilin-1; Prodrugs | 2015 |
NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer's Disease.
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Disulfides; Drug Combinations; Galantamine; Humans; Levodopa; Plaque, Amyloid | 2015 |
Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Carotid Stenosis; Cholinesterase Inhibitors; Disease Models, Animal; Galantamine; Gene Expression Regulation; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Models, Cardiovascular; Plaque, Amyloid; Postural Balance; Psychomotor Performance; Receptors, Nicotinic; White Matter | 2016 |
Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Cytoprotection; Dose-Response Relationship, Drug; Galantamine; Glutathione; Lipid Peroxidation; Nerve Degeneration; Neurons; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Plaque, Amyloid; Rats | 2009 |
Drugs for Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Drug Design; Excitatory Amino Acid Antagonists; Galantamine; Humans; Memantine; Plaque, Amyloid | 2012 |